SAM
SCMP

Shamrock Asset Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Shamrock Asset Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-600
Closed -$7K – 288
2016
Q1 		$7K Buy
600
+300
+100% +$3.79K ﹤0.01% 219
2015
Q4 		$5K Hold
300
– – ﹤0.01% 230
2015
Q3 		$6K Buy
+300
New +$6.88K ﹤0.01% 222

Other funds holding SCMP

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Shamrock Asset Management's SCMP Position: Q2 2016 in Review

Shamrock Asset Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2016, closing a stake of 600 shares — an estimated $7K sold.

Shamrock Asset Management first reported a position in SCMP in Q3 2015 and held it in 3 quarters. The position peaked at $7K in Q1 2016. 136 funds tracked by Wall St. Rank hold SCMP as of Q2 2016.

  • Shamrock Asset Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • Shamrock Asset Management sold 600 Sucampo Pharmaceuticals, Inc. shares in Q2 2016, an estimated $7K.
  • Shamrock Asset Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 3 quarters.
  • Shamrock Asset Management's Sucampo Pharmaceuticals, Inc. position peaked at $7K in Q1 2016.
  • 136 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2016.

Based on Shamrock Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.